St. Luke's Cancer Care Associates
Bethlehem, Pennsylvania, United States
Oncologist in Fountain Hill, Pennsylvania
701 Ostrum St Suite 403, Bethlehem, PA 18015
About St. Luke's Cancer Care Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at St. Luke's Cancer Care Associates
During the past decade, St. Luke's Cancer Care Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
2007-05-01
2015-03-01
Completed
520
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
2009-04-29
2012-02-07
Completed
59
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
2006-06-26
2014-09-22
Completed
417
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at St. Luke's Cancer Care Associates
According to Clinical.Site data, the most researched conditions in "St. Luke's Cancer Care Associates" are
"BRAF or NRAS Mutant Metastatic Melanoma" (1 trials), "Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "St. Luke's Cancer Care Associates" in a lesser frequency.
Clinical Trials Intervention Types at St. Luke's Cancer Care Associates
Most popular intervention types in "St. Luke's Cancer Care Associates" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Nab-Paclitaxel" (2 trials), "Paclitaxel" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at St. Luke's Cancer Care Associates
The vast majority of trials in "St. Luke's Cancer Care Associates" are
7 trials for "All" genders.
Clinical Trials Status at St. Luke's Cancer Care Associates
Currently, there are NaN active trials in "St. Luke's Cancer Care Associates".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in St. Luke's Cancer Care Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Luke's Cancer Care Associates, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".